NR 503 Week 4 Midterm Study Questions - Answer
-
$30.00
| Institution | Chamberlain |
| Contributor | Sherrie |
Key Points - Can you answer these questions?
- Question: How does social justice and health inequities influence population health care provision? Why is this critical information for the provision of evidence-based care?
- Question:Are you able to both define and apply key terms, such as:
- Vital statistics
- Morbidity
- Mortality
- Social justice
- Epidemiology
- Population health
- Incidence
- Prevalence
- Outcomes
- inter-professional collaboration
- HP2020
- Determinants of health
- Risk analysis
- Question:What is the Campaign for Action?
- Question:Explain the differences between primary, secondary, and tertiary interventions?
----------------------------------
- Question:Is screening a tertiary intervention? If yes, why, if not, what is it?
- Question:How does a provider determine the usefulness, appropriateness, of a screening test?
- Question:Where would a NP look to find a screening test? What determines if a screening test should be used?
- Question:Can you explain what "descriptive epidemiology" means? What is the purpose? How is it used?
- Question:How are causation and descriptive epidemiology related, how do they work together to aid evidence-based care?
- Question:What does "causation" mean? Can you relate causation to primary, secondary and tertiary interventions?
----------------------------------
- Question:What is a case-control study and how does it differ (or how is it the same) as the cohort study design?
- Question:Can you talk about the ways bias shows up in a study design (such as, selection bias) etc.?
- Question:What is different in a randomized control trial than, for instance, a case-control study (or a cohort study)? What does it mean to show a causal relationship?
- Question:What is each type of study used for, its purpose, and its outcomes? How are the outcomes different in each study design? Measured?
- Question:What is an intervention group? Where is it found?
- Question:Can you explain a retrospective versus a prospective study design? What are the pros and cons of each?
- Question:How are groups selected for each of the study designs?
- Question:What is meant by "scientific misconduct"?
- Question:Differentiate: random error, systematic error, confounding error.
- Question:What are methods to measure health outcomes?
- Question:What are elements of the Action Model?
- Question:Action model to achieve healthy people 2020 overarching goals
- Question:Levels of Evidence
- Question:Web site reliability
- Question:Rapid cycle improvement model
- Question:The PDSA cycle for learning and improving
----------------------------------
- Question:What is the highest level of data findings? How is evidence appraised?
- Question:Can you describe the various levels of studies and how they are rated in terms of their use for integration into practice?
- Question:How is a website's credibility determined?
- Question:What are key indicators when assessing a model of care?
- Question:How would you explain the Triple Aim initiative (model) to a colleague?
| Instituition / Term | |
| Term | Session 2019 |
| Institution | Chamberlain |
| Contributor | Sherrie |
